A tight association between HIF1α expression and poor prognosis and survival has been reported in different cancers including colorectal cancer, non-small-cell lung cancer (NSCLC) and pancreatic ductal adenocarcinomas patients [14,15,16]. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.